TRIUMF, Canada's national laboratory for particle and nuclear physics, wants to help industry help hospitals produce their own medical isotopes and deliver personalized medicine to people suffering from cancer, neurological or cardiac diseases. TRIUMF has spun-off the Advanced Applied Physics Solutions (AAPS), which is partnering with industry on several joint ventures and the launch of four new companies to fully exploit the commercial potential of Canada's global expertise in applied physics.

Promising technologies including desktop-sized cyclotrons, which would enable hospitals to generate their own medical isotopes for diagnostics and therapeutics. AAPS also plans to develop a new medical imaging that can detect small tumours sooner, rare isotopes that can destroy cancerous cells with minimal damage to healthy tissue and a subterranean detector technology for locating high-density mineral deposits.

Advanced Applied Physics Solutions Inc. - AAPS (2008-2013)
Focus:	To commercialize advanced physics technologies for the social and economic well-being of Canadians, and to advance the development of physics applications for the benefit of people around the world.
Funding:	$14.95 million for entire funding period
Partnership Power:	$418,792 in in-kind support
Centre Director:	Dr. Philip Gardner
Web site:	www.aapsinc.com